These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11165996)
1. Cyclooxygenase-2: a major therapeutic advance? Emery P Am J Med; 2001 Jan; 110(1A):42S-45S. PubMed ID: 11165996 [TBL] [Abstract][Full Text] [Related]
2. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Hochberg MC Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069 [TBL] [Abstract][Full Text] [Related]
3. COX-2-selective inhibitors in the treatment of arthritis. Schnitzer TJ; Hochberg MC Cleve Clin J Med; 2002; 69 Suppl 1():SI20-30. PubMed ID: 12086290 [TBL] [Abstract][Full Text] [Related]
4. Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors. Scheiman JM Cleve Clin J Med; 2002; 69 Suppl 1():SI40-6. PubMed ID: 12086292 [TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Spiegel BM; Targownik L; Dulai GS; Gralnek IM Ann Intern Med; 2003 May; 138(10):795-806. PubMed ID: 12755551 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and prostaglandins in articular tissues. Martel-Pelletier J; Pelletier JP; Fahmi H Semin Arthritis Rheum; 2003 Dec; 33(3):155-67. PubMed ID: 14671726 [TBL] [Abstract][Full Text] [Related]
14. An update on specific COX-2 inhibitors: the COXIBs. Gupta S; Crofford LJ Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091 [No Abstract] [Full Text] [Related]